Marie-pierre P. Sunyach

28, Rue Laennec
Lyon, 69008, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 17, 2026

Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohort.

Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohort.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 21, 2026

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 08, 2026

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 08, 2026

Reirradiation: A new therapeutic paradigm in oncology

Reirradiation: A new therapeutic paradigm in oncology

Journal: Bulletin du cancer
Published: October 21, 2025

The French Reirradiation Team for Research and Treatment (FReTREAT): A national collaborative model by Unitrad for advancing reirradiation research, education, and clinical practice in France.

The French Reirradiation Team for Research and Treatment (FReTREAT): A national collaborative model by Unitrad for advancing reirradiation research, education, and clinical practice in France.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: June 27, 2025

Reirradiation of lung, breast and bone tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.

Reirradiation of lung, breast and bone tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: June 16, 2025

Multi-institutional virtual peer review for reirradiation: dedicated workflow and one-year results.

Multi-institutional virtual peer review for reirradiation: dedicated workflow and one-year results.

Journal: Technical innovations & patient support in radiation oncology
Published: June 13, 2025

A dedicated institutional clinical workflow and peer-review meeting for reirradiation.

A dedicated institutional clinical workflow and peer-review meeting for reirradiation.

Journal: Technical innovations & patient support in radiation oncology
Published: May 30, 2025

Radiotherapy and brachytherapy in the management of adult soft tissue sarcomas.

Radiotherapy and brachytherapy in the management of adult soft tissue sarcomas.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: May 15, 2025

Radiotherapy and brachytherapy in the management of adult soft tissue sarcomas.

Radiotherapy and brachytherapy in the management of adult soft tissue sarcomas.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: May 15, 2025

First case report of radiation-recall myositis following trabectedin in patient with stage IV mesenchymal chondrosarcoma.

First case report of radiation-recall myositis following trabectedin in patient with stage IV mesenchymal chondrosarcoma.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: March 11, 2025
Showing 1-12 of 63

Last Updated: 09/26/2026